secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001493152-24-025267
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Biotherapeutics appoints Dr. George Peoples to board effective July 1, 2024
--------------------------------------------------------------------------------

- Appointed Dr. George Peoples as director effective July 1, 2024; term expires at 2025 annual meeting.
- Dr. Peoples will serve on the Compensation Committee upon appointment.
- Background: 30-year military surgeon, research scientist, Founder/CEO of Cancer Insight.
- Compensation per nonemployee director policy; standard indemnification agreement to be entered.
- No arrangements or family relationships with directors/officers disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224025267/0001493152-24-025267-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224025267/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-025267

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer